RxSight Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for RxSight, Inc. (RXST) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-27.46-48.61-66.76-48.6927.58
Depreciation & Amortization3.624.534.023.994.01
Stock Based Compensation24.6415.7511.407.584.19
Change in Working Capital-9.21-9.07-7.41-2.68-7.85
Change in Accounts Receivable-9.80-9.33-6.09-2.00-2.08
Change in Inventory-4.99-2.75-7.56-2.11-1.31
Change in Accounts Payable0.951.250.640.56-0.95
Change in Other Working Capital4.641.750.550.49-3.51
Other Operating Activities0.409.790.550.49-62.77
Net Cash from Operating Activities-16.95-41.59-58.85-44.71-35.20
Investing Activities
Capital Expenditures-5.444.81-2.39-1.94-2.54
Purchases of Investments-93.87-17.32-212.66-159.9718.13
Sales/Maturities of Investments243.00255.00255.0080.000.00
Other Investing Activities-99.310.000.000.000.00
Net Cash from Investing Activities-99.31-22.1339.95-81.9115.59
Financing Activities
Debt Repayment-0.06-60.15-0.12-0.030.00
Common Stock Issued128.92105.967.83121.141.04
Common Stock Repurchased-4.77-1.42-0.640.000.00
Other Financing Activities-0.77-2.86-1.380.44-0.69
Net Cash from Financing Activities123.3261.526.33137.3425.24
Summary
Effect of Forex Changes on Cash-0.010.01-0.01-0.010.00
Net Change in Cash7.05-2.19-12.5710.735.63
Cash at Beginning of Period10.4012.6025.1714.460.00
Cash at End of Period17.46208.5912.6025.170.00
Free Cash Flow-22.39-46.41-61.24-46.65-37.74
Supplemental Disclosures
Interest Paid0.023.484.263.190.43
Income Taxes Paid0.020.010.000.020.06